Higher sitting time increases the risk of all‐cause, cancer‐specific, and noncancer mortality
Sign Up to like & getrecommendations! Published in 2022 at "Cancer"
DOI: 10.1002/cncr.34203
Abstract: Future Considerations Although the blood test/PLCOm2012 model could be implemented as a laboratory-developed test in the near future, Food and Drug Administration approval would likely require an evaluation through a prospective clinical trial. However, the… read more here.
Keywords: higher sitting; sitting time; test; risk ... See more keywords